-+ 0.00%
-+ 0.00%
-+ 0.00%

Delcath Systems Sees 2025 CHEMOSAT And HEPZATO KIT Revenue Climbing To $94M–$98M In 2025, Up Over 150% YoY, Sees 83%–85% Gross Margins

Benzinga·05/22/2025 11:08:24
Listen to the news
  • 2025 Full Year Total Revenue Guidance of $94 to $98 million
  • Delcath Announces Plan to Enter into National Medicaid Drug Rebate Agreement